en English

Abstract

Gonadotropin-releasing hormone analogs (GnRHa) are widely used to treat central precocious puberty (CPP).

The efficacy and safety of GnRHa treatment are known, but concerns regarding long-term complications are increasing. Follow-up observation results after GnRHa treatment cessation in female CPP patients up to adulthood showed that…

 

Read the full publication

 

Photo by Hush Naidoo on Unsplash